Predicts event-free survival in intermediate-risk paediatric Hodgkin lymphoma.
The CHIPS — Childhood Hodgkin Prognostic Score is a oncology scoring tool used in paediatric practice. Predicts event-free survival in intermediate-risk paediatric Hodgkin lymphoma. It scores 4 criteria and interprets the total across 4 bands, so the number always arrives with the severity it implies rather than on its own. In PediAid each criterion is shown as a labelled option with the weight it carries, so the total can be checked rather than taken on trust.
4. They are Stage 4 disease; Large mediastinal mass; Serum albumin < 3.5 g/dL; Fever (B symptom).
The total is interpreted as: any score - Low risk: cHIPS 0 - approximately 93% 4-year event-free survival. Standard therapy; 1 point or more - Intermediate: cHIPS 1 - approximately 89% 4-year EFS; 2 points or more - Higher risk: cHIPS 2 - approximately 81% 4-year EFS. Consider response-adapted intensification; 3 points or more - High risk: cHIPS 3-4 - approximately 70% 4-year EFS. Higher-intensity therapy and close response assessment.
No. It is a structured way to record and communicate severity. A clinician concerned about a child should act on that concern regardless of the total.
Derived in COG AHOD0031 (intermediate-risk Hodgkin lymphoma).
Yes. Score definitions are bundled with the PediAid app, so the score computes without a connection.